Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia Hematology, May 24, 2013 Clinical Article
2 Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters Haemophilia, May 24, 2013 Clinical Article
3 Alloantibodies in previously untreated hemophilia A patients: the role of environmental factors Hematology, May 24, 2013 Clinical Article
4 Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan Blood Cells, Molecules, and Diseases, May 24, 2013 Clinical Article
5 Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients Haemophilia, May 23, 2013 Clinical Article
6 Prevalence and molecular characterization of β-thalassemia in the state of bahia, brazil: first identification of mutation HBB: c.135delC in brazil Hemoglobin, May 23, 2013 Clinical Article
7 Safety and efficacy of splenectomy in over-65 year old patients with immune thrombocytopenia European Journal of Haematology, May 22, 2013 Clinical Article
8 Effect of zinc supplementation on serum antibody titers to heat shock protein 27 in patients with thalassemia major Hematology, May 22, 2013 Clinical Article
9 Bypass therapy assay testing as a strategy to reduce costs for treatment of haemophilia patients with inhibitors Haemophilia, May 22, 2013 Clinical Article
10 Inhibiting the intrinsic pathway of coagulation with a FXII-targeting RNA Aptamer Journal of Thrombosis and Haemostasis, May 22, 2013 Review Article
11 Acquired hemophilia A caused by factor VIII inhibitors: report of a case Surgery Today, May 22, 2013
12 Normal cleavage of von Willebrand factor by ADAMTS13 in the absence of factor VIII in patients with severe hemophilia A Journal of Thrombosis and Haemostasis, May 21, 2013 Clinical Article
13 Effect of Antioxidant Therapy on Hepatic Fibrosis and Liver Iron Concentrations in β-Thalassemia Major Patients Hemoglobin, May 21, 2013 Clinical Article
14 Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation New England Journal of Medicine, May 20, 2013 Evidence Based Medicine Clinical Article
15
Renal diseases in haemophilic patients: pathogenesis and clinical management
European Journal of Haematology, May 17, 2013
Clinical Article
Exclusive Author Commentary
16 Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort Vox Sanguinis, May 15, 2013 Clinical Article
17 Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors - a thrombin generation-guided pilot study Haemophilia, May 15, 2013 Clinical Article
18 Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers AIDS, May 15, 2013 Clinical Article
19 Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function Blood Coagulation & Fibrinolysis, May 15, 2013 Clinical Article
20 Recurrent jejunal bleeding due to angiodysplasia in a Bernard-Soulier patient Blood Coagulation & Fibrinolysis, May 15, 2013
As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.
Read the article summaryAs reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.
Read the article summaryAs reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.
Read the article summary1 Management and outcomes for patients with TTP: Analysis of 100 cases at a single institution American Journal of Hematology, April 29, 2013
2 Anticoagulation for prevention and treatment of cancer-related venous thromboembolism British Journal of Haematology, April 9, 2013
3
Adherence to anticoagulant treatment with dabigatran in a real-world setting
Journal of Thrombosis and Haemostasis, April 19, 2013
Exclusive Author Commentary
4 Impact of a venous thromboembolism (VTE) prophylaxis smart order set: Improved compliance, fewer events American Journal of Hematology, April 8, 2013
5 Bleeding risk in warfarinized patients with a therapeutic INR: the effect of low factor IX levels Journal of Thrombosis and Haemostasis, April 18, 2013
6 Intracranial haemorrhage in von Willebrand disease: a report on six cases Haemophilia, April 23, 2013
7 Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside British Journal of Haematology, April 25, 2013 Review Article
8 ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment Transfusion, April 10, 2013
9 Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation Thrombosis and Haemostasis, April 23, 2013
10 The predictive ability of bleeding risk stratification models in very old patients on VKA treatment for venous thromboembolism Results of the Prospective Collaborative EPICA study Journal of Thrombosis and Haemostasis, April 15, 2013
11 FcRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia Journal of Thrombosis and Haemostasis, April 3, 2013
12 Unresponsive thrombotic thrombocytopenic purpura in critically ill adults Intensive Care Medicine, April 5, 2013
13 Statin Therapy and Levels of Hemostatic Factors in a Healthy Population: the Multi-Ethnic Study of Atherosclerosis Journal of Thrombosis and Haemostasis, April 11, 2013
14 Post-thrombotic syndrome: a clinical review Journal of Thrombosis and Haemostasis, March 8, 2013 Review Article
15 Product-dependent anti-factor VIII antibodies Haemophilia, April 25, 2013
16 Anticoagulant use in patients with cancer associated venous thromboembolism: A retrospective cohort study Thrombosis Research, March 22, 2013 Evidence Based Medicine
17 Plasma concentration of protein Z and protein Z-dependent protease inhibitor in patients with haemophilia A Thrombosis Research, April 2, 2013 Evidence Based Medicine
18 Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban Thrombosis Research, April 2, 2013
19 Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study British Journal of Haematology, April 26, 2013 Review Article
20 Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1 Haemophilia, April 11, 2013
Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close